Do you wonder if your peers in the industry have the same worries, struggles and fears that you do when it comes to #patientaccess? It can be hard to be that vulnerable! We have some good news! MMIT (Managed Markets Insight & Technology) just talked to over 300 of your peers - pharma execs - to learn what’s keeping them up at night—and what gets them going in the morning. Check out the findings and our expert analysis in MMIT’s first-annual State of Patient Access research report. Have questions? Want to talk about it? Let us know! https://lnkd.in/eW7JHTAE
Pharma Marketing Canada’s Post
More Relevant Posts
-
🚨 Polypharmacy: A Growing Concern in Healthcare 🚨 In today's complex healthcare environment, managing multiple medications for a single patient—often referred to as polypharmacy—has become increasingly common. While it can be necessary for managing chronic conditions, it also comes with risks like adverse drug interactions, patient non-adherence, and reduced quality of life. 💊 So, what can healthcare professionals do to manage this more effectively? In my latest article, I explore: The challenges of polypharmacy. Strategies for healthcare professionals to optimise patient outcomes. The role of technology and data analytics in improving medication management. This is an important issue, especially as our aging population and prevalence of chronic diseases grow. I'd love to hear your thoughts and experiences—how do you or your organization handle the complexities of polypharmacy? 👉 Read the full article: https://lnkd.in/gPx8VhSc #Healthcare #Polypharmacy #PatientSafety #ChronicDisease #MedicationManagement #DigitalHealth #HealthTech #Pharmacy
To view or add a comment, sign in
-
🌟 #ICYMI: ADVI Health's chief commercial officer, Sarah Butler, recently participated in ConnectiveRx's webinar, "Bracing for Impact: The Future of Hub, PAP, and Affordability Programs Under the Inflation Reduction Act." Throughout the discussion, Sarah shared insight on the #InflationReductionAct (IRA)'s long-term consequences on drug development, what clients expect from #IRA shifts, and more. Tune into the full webinar and hear more on Sarah's insights and discussion with other #healthcare experts: https://lnkd.in/en_gE5AD
To view or add a comment, sign in
-
Don't miss out on the power of collaboration! While competition is a driving force, fostering partnerships holds immense potential for businesses of all sizes. By combining resources, expertise, and perspectives, collaborations can unlock innovation, market expansion, reduced costs, etc. Yet, in my experience in business development, many people/companies still hesitate to accept the outreach for some unknown cautions. At a bare minimum take a call to build a relationship and learn something. Remember, collaboration isn't about immediate gain, but fostering long-term, mutually beneficial relationships. Take the time to truly listen to potential partners and explore potential synergies. Risk / Reward #collaboration #business #synergy #partnership #growthmindset
Aptar Digital Health is pleased to be at the forefront to include the voice of the patient in the next generation of drug delivery. Our recently announced collaboration with Gerresheimer marks a step towards enhancing patient experiences and treatment outcomes. Aptar Digital Health President, Sai Shankar spoke with pharmaphorum’s about our collaboration with Gerresheimer and how we are helping to make healthcare more personalized and efficient. Read the article: https://lnkd.in/e_8fyATJ Mithun Ratnakumar, Emre Ozcan, PhD
To view or add a comment, sign in
-
In this video Brian Nightengale discusses how data and analytics can be leveraged to improve pharmacy’s financial and operational performance while enhancing patient care
Watch our Healthcare leader, Brian Nightengale, discuss enhancing patient care and boosting operational productivity with data-driven tools in a recent interview with Chain Drug Review. #HealthcareInnovation #PatientCare #DataDrivenSolutions #InmarJourney
Video Forum: Brian Nightengale, Inmar Intelligence - CDR – Chain Drug Review
https://www.chaindrugreview.com
To view or add a comment, sign in
-
Even as someone who has worked on consumer health a fair bit, I find it hard to keep up with all of the over-the-counter options available. When would I use drug X rather than drug Y? Wait, drug Z is out now, should I use it instead? Merck asked Innovia Technology to take a holistic approach to the challenge and map out the different biological, medical, behavioural and psychological factors that they should consider when preparing a new launch. Read more about the work over on our Consumer Health Hub: https://lnkd.in/ectQVMxA #ConsumerHealth #Medication #Innovation
Improving access to restricted drugs with Merck.
To view or add a comment, sign in
-
Watch our Healthcare leader, Brian Nightengale, discuss enhancing patient care and boosting operational productivity with data-driven tools in a recent interview with Chain Drug Review. #HealthcareInnovation #PatientCare #DataDrivenSolutions #InmarJourney
Video Forum: Brian Nightengale, Inmar Intelligence - CDR – Chain Drug Review
https://www.chaindrugreview.com
To view or add a comment, sign in
-
Point-of-Care Diagnostics: Explore current and future trends, including technological breakthroughs and therapeutic approaches for enhanced patient outcomes Stay informed on ongoing trials to improve accessibility and precision in diagnostic technologies, fostering better patient care. Identify growth prospects and challenges in Point-of-Care Diagnostics, focusing on diverse diagnostic scenarios and the evolving healthcare landscape Gain insights into industry leaders driving innovation focusing on enhancing accessibility and independence in addressing diverse healthcare needs For detailed report: https://lnkd.in/gQFVtdJJ Request customized report: https://lnkd.in/d6q8Q-5a #pointofcare #poc #PointofCareDiagnostics #marketreport #Clinicaltrial #ProductAnalysis #PatentAnalysis #CompetitiveAnalysis #MarketForecast
𝐏𝐨𝐢𝐧𝐭-𝐨𝐟-𝐂𝐚𝐫𝐞 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬: Explore current and future trends, including technological breakthroughs and therapeutic approaches for enhanced patient outcomes. Stay informed on ongoing trials to improve accessibility and precision in diagnostic technologies, fostering better patient care. Identify growth prospects and challenges in Point-of-Care Diagnostics, focusing on diverse diagnostic scenarios and the evolving healthcare landscape. Gain insights into industry leaders driving innovation, focusing on enhancing accessibility and independence in addressing diverse healthcare needs. For detailed report: https://lnkd.in/gQFVtdJJ Request customized report: https://lnkd.in/d6q8Q-5a #pointofcare #poc #PointofCareDiagnostics #marketreport #Clinicaltrial #ProductAnalysis #PatentAnalysis #CompetitiveAnalysis #MarketForecast
To view or add a comment, sign in
-
Elligo Health Research provides the full administrative support needed to bring clinical research to your practice, helping you elevate patient care and optimize practice revenue. #Neurology #Cardiology #Pulmonology #ClinicalResearch #PrivatePractice #PatientCare #HealthcareInnovation #PracticeGrowth
Why are we the partner of choice for physicians and sites? This video says it all ⏬ It’s time to increase your revenue, offer additional care options to your patients, and help advance the development of new medicines and therapies! Learn how to join our research network now: https://ow.ly/Jw4o50T6Tay #clinicaltrials #clinicalresearch #patientcentricity
To view or add a comment, sign in
-
By understanding more about a medication’s use in the real world, away from clinical settings, pharma companies and care providers have an opportunity to improve care, make it more personalised and patient centric and reduce health inequalities. In this paper, we explore the role of real-world patient data in improving health outcomes. Download now to understand the transformative power of patient reported data. https://lnkd.in/eiQDwMRt #patientreporteddata #realworldevidence #patientinsights #pharma
To view or add a comment, sign in
1,079 followers